Binding of Epstein-Barr virus nuclear antigen 1 to DNA: inhibition by distamycin and two novel distamycin analogues
- 1 April 1994
- journal article
- Published by Elsevier in European Journal of Pharmacology: Molecular Pharmacology
- Vol. 267 (2) , 143-149
- https://doi.org/10.1016/0922-4106(94)90165-1
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- TAPP (tetra-p-amidinophenoxyneopentane) inhibits the binding of nuclear factors to target DNA sequencesInternational Journal of Pharmaceutics, 1991
- HIV enhancer activity perpetuated by NF-κB induction on infection of monocytesNature, 1991
- Distamycin inhibits the binding of a nuclear factor to the -278/-256 upstream sequence of the human HLA-DRα geneBiochemical Pharmacology, 1991
- Human HLA-DRα gene: a rare oligonucleotide (GTATA) identifies an upstream sequence required for nuclear protein bindingFEBS Letters, 1990
- Distamycins inhibit the binding of OTF-1 and NFE-1 transfactors to their conserved DNA elementsNucleic Acids Research, 1989
- Selection of DNA binding sites by regulatory proteinsTrends in Biochemical Sciences, 1988
- Molecular recognition between oligopeptides and nucleic acids. Monocationic imidazole lexitropsins that display enhanced GC sequence dependent DNA bindingBiochemistry, 1987
- Purification and Biochemical Characterization of the Promoter-Specific Transcription Factor, Sp1Science, 1986
- Design of Sequence-Specific DNA-Binding MoleculesScience, 1986
- Molecular recognition of B-DNA by Hoechst 33258Nucleic Acids Research, 1985